Can a pill clear the fog on mammograms? new trial hopes so
NCT ID NCT07434128
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This phase II trial tests whether taking ulipristal acetate before a mammogram can temporarily reduce breast density in premenopausal people with extremely dense breast tissue. Dense tissue can hide cancers on mammograms, so lowering density may improve screening accuracy. The study will enroll 26 participants and compare breast density changes from their baseline mammogram to one after taking the drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ulipristal acetate
What this could lead to
If it works, this could make mammograms more accurate for people with dense breasts, potentially catching cancer earlier.
What could go wrong
This is a small early-phase trial with only 26 participants, so results may not apply widely. The drug only temporarily lowers breast density and may not improve cancer detection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAMMOGRAPHY SCREENING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact